{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:12:41Z","timestamp":1793232761664,"version":"4.5.0"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014989","name":"Chan Zuckerberg Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014989","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005031","name":"Bhabha Atomic Research Centre","doi-asserted-by":"publisher","award":["2020-225716"],"award-info":[{"award-number":["2020-225716"]}],"id":[{"id":"10.13039\/501100005031","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000923","name":"Silicon Valley Community Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["P30CA016086"],"award-info":[{"award-number":["P30CA016086"]}],"id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["R01AI137273"],"award-info":[{"award-number":["R01AI137273"]}],"id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["R03AI148822"],"award-info":[{"award-number":["R03AI148822"]}],"id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","award":["R33CA206939"],"award-info":[{"award-number":["R33CA206939"]}],"id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006808","name":"University of North Carolina","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006808","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biofilm"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.bioflm.2021.100049","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T13:54:55Z","timestamp":1620741295000},"page":"100049","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"C","title":["Harnessing ultrasound-stimulated phase change contrast agents to improve antibiotic efficacy against methicillin-resistant Staphylococcus aureus biofilms"],"prefix":"10.1016","volume":"3","author":[{"given":"Phillip G.","family":"Durham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashelyn E.","family":"Sidders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenna E.","family":"Beam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna M.","family":"Kedziora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Dayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Conlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8955-359X","authenticated-orcid":false,"given":"Sarah E.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioflm.2021.100049_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.15585\/mmwr.mm6809e1","article-title":"Vital signs: epidemiology and recent trends in methicillin-resistant and in methicillin-susceptible Staphylococcus aureus bloodstream infections - United States","volume":"68","author":"Kourtis","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Suppl 5","key":"10.1016\/j.bioflm.2021.100049_bib2","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1086\/533590","article-title":"Epidemiology of methicillin-resistant Staphylococcus aureus","volume":"46","author":"Boucher","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2021.100049_bib3","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care-associated infections in U.S. Hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bioflm.2021.100049_bib4","first-page":"199","article-title":"Staphylococcus aureus-associated skin and soft tissue infections: anatomical localization, epidemiology, therapy and potential prophylaxis","volume":"409","author":"Olaniyi","year":"2017","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.bioflm.2021.100049_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.tim.2013.06.002","article-title":"The in vivo biofilm","volume":"21","author":"Bjarnsholt","year":"2013","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ppul.21011","article-title":"Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients","volume":"44","author":"Bjarnsholt","year":"2009","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.bioflm.2021.100049_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122688","article-title":"The consequences of being in an infectious biofilm: microenvironmental conditions governing antibiotic tolerance","volume":"18","author":"Sonderholm","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bioflm.2021.100049_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrmicro1838","article-title":"Physiological heterogeneity in biofilms","volume":"6","author":"Stewart","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0140-6736(01)05321-1","article-title":"Antibiotic resistance of bacteria in biofilms","volume":"358","author":"Stewart","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bioflm.2021.100049_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1128\/AAC.45.4.999-1007.2001","article-title":"Riddle of biofilm resistance","volume":"45","author":"Lewis","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0966-842X(00)01913-2","article-title":"Mechanisms of biofilm resistance to antimicrobial agents","volume":"9","author":"Mah","year":"2001","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib12","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.tim.2019.05.003","article-title":"Antimicrobial tolerance and metabolic adaptations in microbial biofilms","volume":"27","author":"Crabbe","year":"2019","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.micro.112408.134306","article-title":"Persister cells","volume":"64","author":"Lewis","year":"2010","journal-title":"Annu Rev Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib14","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrmicro2333","article-title":"How antibiotics kill bacteria: from targets to networks","volume":"8","author":"Kohanski","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006012","article-title":"Convergence of Staphylococcus aureus persister and biofilm Research: can biofilms Be defined as communities of adherent persister cells?","volume":"12","author":"Waters","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.bioflm.2021.100049_bib16","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1128\/AEM.02636-13","article-title":"Bacterial persister cell formation and dormancy","volume":"79","author":"Wood","year":"2013","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib17","first-page":"107","article-title":"Multidrug tolerance of biofilms and persister cells","volume":"322","author":"Lewis","year":"2008","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.bioflm.2021.100049_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/1751-7915.12774","article-title":"Strategies for combating persister cell and biofilm infections","volume":"10","author":"Wood","year":"2017","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.bioflm.2021.100049_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature12790","article-title":"Activated ClpP kills persisters and eradicates a chronic biofilm infection","volume":"503","author":"Conlon","year":"2013","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bioflm.2021.100049_bib20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.chembiol.2019.07.009","article-title":"Chemical induction of aminoglycoside uptake overcomes antibiotic tolerance and resistance in Staphylococcus aureus","volume":"26","author":"Radlinski","year":"2019","journal-title":"Cell Chem Biol."},{"key":"10.1016\/j.bioflm.2021.100049_bib21","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/AAC.00181-13","article-title":"A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms","volume":"57","author":"Bauer","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2003981","article-title":"Pseudomonas aeruginosa exoproducts determine antibiotic efficacy against Staphylococcus aureus","volume":"15","author":"Radlinski","year":"2017","journal-title":"PLoS Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib23","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/jac\/dkq257","article-title":"Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms","volume":"65","author":"Singh","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib24","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftw056","article-title":"Penetration barrier contributes to bacterial biofilm-associated resistance against only select antibiotics, and exhibits genus-, strain- and antibiotic-specific differences","volume":"74","author":"Singh","year":"2016","journal-title":"Pathog Dis"},{"key":"10.1016\/j.bioflm.2021.100049_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02696-16","article-title":"Importance of the exopolysaccharide matrix in antimicrobial tolerance of Pseudomonas aeruginosa aggregates","volume":"61","author":"Goltermann","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib26","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/1462-2920.12155","article-title":"The extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycin","volume":"15","author":"Tseng","year":"2013","journal-title":"Environ Microbiol"},{"key":"10.1016\/j.bioflm.2021.100049_bib27","doi-asserted-by":"crossref","first-page":"843","DOI":"10.4155\/tde.14.32","article-title":"Ultrasound-enhanced transdermal delivery: recent advances and future challenges","volume":"5","author":"Oberli","year":"2014","journal-title":"Ther Deliv"},{"key":"10.1016\/j.bioflm.2021.100049_bib28","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.2174\/138920112800624364","article-title":"Ultrasound-induced blood-brain barrier opening","volume":"13","author":"Konofagou","year":"2012","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"10.1016\/j.bioflm.2021.100049_bib29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0301-5629(01)00441-0","article-title":"\u201cStable\u201d inertial cavitation","volume":"27","author":"Church","year":"2001","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib30","first-page":"743","article-title":"Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications","volume":"14","author":"Tzu-Yin","year":"2013","journal-title":"Curr Pharmaceut Biotechnol"},{"key":"10.1016\/j.bioflm.2021.100049_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/jac\/dkh518","article-title":"Liposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients","volume":"55","author":"Mugabe","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/jac\/dkn059","article-title":"Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections","volume":"61","author":"Meers","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib33","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1016\/j.ultrasmedbio.2020.07.008","article-title":"A comparison of sonothrombolysis in aged clots between low-boiling-point phase-change nanodroplets and microbubbles of the same composition","volume":"46","author":"Kim","year":"2020","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib34","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1016\/j.ultrasmedbio.2020.06.021","article-title":"Investigating the accumulation of submicron phase-change droplets in tumors","volume":"46","author":"Helfield","year":"2020","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib35","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ultrasmedbio.2018.02.006","article-title":"Accelerated clearance of ultrasound contrast agents containing polyethylene glycol is associated with the generation of anti-polyethylene glycol antibodies","volume":"44","author":"Fix","year":"2018","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib36","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1016\/j.ultrasmedbio.2015.04.002","article-title":"Acoustic cavitation-mediated delivery of small interfering ribonucleic acids with phase-shift nano-emulsions","volume":"41","author":"Burgess","year":"2015","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib37","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ultrasmedbio.2012.10.004","article-title":"Characterization of submicron phase-change perfluorocarbon droplets for extravascular ultrasound imaging of cancer","volume":"39","author":"Williams","year":"2013","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib38","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40349-017-0085-z","article-title":"An evaluation of the sonoporation potential of low-boiling point phase-change ultrasound contrast agents in vitro","volume":"5","author":"Fix","year":"2017","journal-title":"J Ther Ultrasound"},{"key":"10.1016\/j.bioflm.2021.100049_bib39","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1016\/j.biomaterials.2012.01.021","article-title":"Design of ultrasonically-activatable nanoparticles using low boiling point perfluorocarbons","volume":"33","author":"Sheeran","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioflm.2021.100049_bib40","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ultrasmedbio.2017.10.016","article-title":"In vivo assessment of the potential for renal bio-effects from the vaporization of perfluorocarbon phase-change contrast agents","volume":"44","author":"Nyankima","year":"2018","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib41","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1128\/AAC.00001-13","article-title":"Extracellular DNA shields against aminoglycosides in Pseudomonas aeruginosa biofilms","volume":"57","author":"Chiang","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib42","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/0142-9612(96)00022-1","article-title":"Effect of low-intensity ultrasound upon biofilm structure from confocal scanning laser microscopy observation","volume":"17","author":"Qian","year":"1996","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioflm.2021.100049_bib43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0301-5629(90)90045-E","article-title":"Macrophage responsiveness to therapeutic ultrasound","volume":"16","author":"Young","year":"1990","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib44","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.cellsig.2007.12.005","article-title":"Low intensity pulsed ultrasound accelerates macrophage phagocytosis by a pathway that requires actin polymerization, Rho, and Src\/MAPKs activity","volume":"20","author":"Zhou","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.bioflm.2021.100049_bib45","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.ultrasmedbio.2019.02.004","article-title":"Ultrasound-stimulated phase-change contrast agents for transepithelial delivery of macromolecules, toward gastrointestinal drug delivery","volume":"45","author":"Fix","year":"2019","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib46","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1042\/bj1910209","article-title":"Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase","volume":"191","author":"Hughes","year":"1980","journal-title":"Biochem J"},{"key":"10.1016\/j.bioflm.2021.100049_bib47","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1016\/S1074-5521(00)00116-2","article-title":"Vancomycin resistance in enterococci: reprogramming of the D-ala-D-Ala ligases in bacterial peptidoglycan biosynthesis","volume":"7","author":"Healy","year":"2000","journal-title":"Chem Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib48","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1093\/jac\/dkl424","article-title":"Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus","volume":"58","author":"Barcia-Macay","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib49","first-page":"97","article-title":"Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment","volume":"15","author":"Schwalm","year":"2004","journal-title":"Can J Infect Dis"},{"key":"10.1016\/j.bioflm.2021.100049_bib50","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s40780-018-0123-1","article-title":"Effect of coadministration of rifampicin on the pharmacokinetics of linezolid: clinical and animal studies","volume":"4","author":"Hashimoto","year":"2018","journal-title":"J Pharm Health Care Sci"},{"key":"10.1016\/j.bioflm.2021.100049_bib51","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1038\/s41467-020-15257-1","article-title":"Ca(2+)-Daptomycin targets cell wall biosynthesis by forming a tripartite complex with undecaprenyl-coupled intermediates and membrane lipids","volume":"11","author":"Grein","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.bioflm.2021.100049_bib52","first-page":"235","article-title":"Staphylococcus aureus persisters tolerant to bactericidal antibiotics","volume":"22","author":"Lechner","year":"2012","journal-title":"J Mol Microbiol Biotechnol"},{"key":"10.1016\/j.bioflm.2021.100049_bib53","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1128\/AAC.00350-06","article-title":"Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm","volume":"51","author":"Raad","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib54","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2021.100049_bib55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3390\/pathogens3030759","article-title":"Role of daptomycin in the induction and persistence of the viable but non-culturable state of Staphylococcus aureus biofilms","volume":"3","author":"Pasquaroli","year":"2014","journal-title":"Pathogens"},{"key":"10.1016\/j.bioflm.2021.100049_bib56","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/jac\/dkt086","article-title":"Antibiotic pressure can induce the viable but non-culturable state in Staphylococcus aureus growing in biofilms","volume":"68","author":"Pasquaroli","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23092392","article-title":"Treatment strategies for infected wounds","volume":"23","author":"Negut","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioflm.2021.100049_bib58","first-page":"25","article-title":"Antibiotics and bacterial resistance in the 21st century","volume":"6","author":"Fair","year":"2014","journal-title":"Perspect Med Chem"},{"key":"10.1016\/j.bioflm.2021.100049_bib59","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/cid\/cit070","article-title":"Seven ways to preserve the miracle of antibiotics","volume":"56","author":"Bartlett","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bioflm.2021.100049_bib60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ultrasmedbio.2019.09.011","article-title":"Sonobactericide: an emerging treatment strategy for bacterial infections","volume":"46","author":"Lattwein","year":"2020","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.bioflm.2021.100049_bib61","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ultras.2016.03.017","article-title":"USMB-induced synergistic enhancement of aminoglycoside antibiotics in biofilms","volume":"69","author":"Ronan","year":"2016","journal-title":"Ultrasonics"},{"key":"10.1016\/j.bioflm.2021.100049_bib62","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s41598-017-18496-3","article-title":"The synergistic bactericidal effect of vancomycin on UTMD treated biofilm involves damage to bacterial cells and enhancement of metabolic activities","volume":"8","author":"Hu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bioflm.2021.100049_bib63","doi-asserted-by":"crossref","first-page":"4679","DOI":"10.2147\/IJN.S134525","article-title":"Stimulated phase-shift acoustic nanodroplets enhance vancomycin efficacy against methicillin-resistant Staphylococcus aureus biofilms","volume":"12","author":"Guo","year":"2017","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.bioflm.2021.100049_bib64","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2292550317693813","article-title":"Low-frequency ultrasound debridement in chronic wound healing: a systematic review of current evidence","volume":"25","author":"Chang","year":"2017","journal-title":"Plast Surg (Oakv)"},{"key":"10.1016\/j.bioflm.2021.100049_bib65","doi-asserted-by":"crossref","first-page":"12674","DOI":"10.1073\/pnas.1914906117","article-title":"Low-frequency ultrasound-mediated cytokine transfection enhances T cell recruitment at local and distant tumor sites","volume":"117","author":"Ilovitsh","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bioflm.2021.100049_bib66","doi-asserted-by":"crossref","first-page":"16347","DOI":"10.1038\/s41598-018-34494-5","article-title":"Enhanced microbubble contrast agent oscillation following 250 kHz insonation","volume":"8","author":"Ilovitsh","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bioflm.2021.100049_bib67","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1073\/pnas.0710217105","article-title":"Epidemic community-associated methicillin-resistant Staphylococcus aureus: recent clonal expansion and diversification","volume":"105","author":"Kennedy","year":"2008","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bioflm.2021.100049_bib68","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/jcpt.12074","article-title":"Pharmacokinetics and pharmacodynamics of levofloxacin injection in healthy Chinese volunteers and dosing regimen optimization","volume":"38","author":"Cao","year":"2013","journal-title":"J Clin Pharm Therapeut"},{"key":"10.1016\/j.bioflm.2021.100049_bib69","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/dkh261","article-title":"Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates","volume":"54","author":"Lanao","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib70","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1093\/jac\/dkl328","article-title":"Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?","volume":"58","author":"Burkhardt","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.bioflm.2021.100049_bib71","article-title":"Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections","volume":"51","author":"MacGowan","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib72","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1128\/AAC.41.12.2670","article-title":"Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide","volume":"41","author":"Peloquin","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib73","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1128\/AAC.00247-06","article-title":"Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers","volume":"50","author":"Benvenuto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bioflm.2021.100049_bib74","doi-asserted-by":"crossref","first-page":"10412","DOI":"10.1021\/la2013705","article-title":"Formulation and acoustic studies of a new phase-shift agent for diagnostic and therapeutic ultrasound","volume":"27","author":"Sheeran","year":"2011","journal-title":"Langmuir"}],"container-title":["Biofilm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207521000071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590207521000071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:58:36Z","timestamp":1762919916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590207521000071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":74,"alternative-id":["S2590207521000071"],"URL":"https:\/\/doi.org\/10.1016\/j.bioflm.2021.100049","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.06.01.127340","asserted-by":"object"}]},"ISSN":["2590-2075"],"issn-type":[{"value":"2590-2075","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing ultrasound-stimulated phase change contrast agents to improve antibiotic efficacy against methicillin-resistant Staphylococcus aureus biofilms","name":"articletitle","label":"Article Title"},{"value":"Biofilm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioflm.2021.100049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100049"}}